Humana Inc. (HUM) Shares Bought by Lazard Asset Management LLC

Lazard Asset Management LLC boosted its stake in Humana Inc. (NYSE:HUM) by 0.6% during the first quarter, Holdings Channel reports. The firm owned 810,257 shares of the insurance provider’s stock after buying an additional 4,801 shares during the period. Lazard Asset Management LLC’s holdings in Humana were worth $167,026,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Baldwin Brothers Inc. MA raised its stake in Humana by 2.7% in the first quarter. Baldwin Brothers Inc. MA now owns 67,441 shares of the insurance provider’s stock valued at $13,902,000 after buying an additional 1,782 shares during the period. Thrivent Financial for Lutherans raised its stake in Humana by 6.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 6,065 shares of the insurance provider’s stock worth $1,235,000 after buying an additional 360 shares during the period. A.R.T. Advisors LLC bought a new stake in Humana during the fourth quarter worth about $3,427,000. Bain Capital Public Equity Management LLC bought a new stake in Humana during the fourth quarter worth about $35,079,000. Finally, Guggenheim Capital LLC raised its stake in Humana by 51.0% in the fourth quarter. Guggenheim Capital LLC now owns 262,580 shares of the insurance provider’s stock worth $53,574,000 after buying an additional 88,685 shares during the period. Institutional investors own 98.92% of the company’s stock.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana Inc. (NYSE HUM) traded down 0.76% on Tuesday, reaching $233.69. The company’s stock had a trading volume of 591,021 shares. The firm has a 50 day moving average price of $230.44 and a 200 day moving average price of $213.49. The stock has a market capitalization of $33.72 billion, a P/E ratio of 23.82 and a beta of 0.90. Humana Inc. has a 52 week low of $150.00 and a 52 week high of $236.82.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The company had revenue of $13.76 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the company earned $1.86 EPS. On average, equities analysts anticipate that Humana Inc. will post $11.15 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, June 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.68%. Humana’s dividend payout ratio is presently 16.24%.

ILLEGAL ACTIVITY WARNING: This story was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/2656104/humana-inc-hum-shares-bought-by-lazard-asset-management-llc.html.

HUM has been the subject of a number of analyst reports. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $256.00 price target for the company in a research report on Monday, May 8th. Jefferies Group LLC restated a “buy” rating and issued a $237.00 price target on shares of Humana in a research report on Friday, March 24th. Argus upgraded Humana from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research report on Friday, June 9th. Finally, Deutsche Bank AG initiated coverage on Humana in a research report on Wednesday, April 5th. They issued a “hold” rating and a $216.00 price target for the company. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $223.16.

In related news, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction on Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now owns 8,150 shares in the company, valued at approximately $1,890,474. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bruce D. Broussard sold 118,231 shares of Humana stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $225.82, for a total transaction of $26,698,924.42. Following the transaction, the chief executive officer now owns 171,170 shares in the company, valued at approximately $38,653,609.40. The disclosure for this sale can be found here. Insiders have sold a total of 138,270 shares of company stock valued at $31,253,863 over the last three months. Corporate insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “HUM”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.